These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 31727878)
1. Schizophrenia polygenic risk score and 20-year course of illness in psychotic disorders. Jonas KG; Lencz T; Li K; Malhotra AK; Perlman G; Fochtmann LJ; Bromet EJ; Kotov R Transl Psychiatry; 2019 Nov; 9(1):300. PubMed ID: 31727878 [TBL] [Abstract][Full Text] [Related]
2. Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study. Rodriguez V; Alameda L; Quattrone D; Tripoli G; Gayer-Anderson C; Spinazzola E; Trotta G; Jongsma HE; Stilo S; La Cascia C; Ferraro L; La Barbera D; Lasalvia A; Tosato S; Tarricone I; Bonora E; Jamain S; Selten JP; Velthorst E; de Haan L; Llorca PM; Arrojo M; Bobes J; Bernardo M; Arango C; Kirkbride J; Jones PB; Rutten BP; Richards A; Sham PC; O'Donovan M; Van Os J; Morgan C; Di Forti M; Murray RM; Vassos E Psychol Med; 2023 Jun; 53(8):3396-3405. PubMed ID: 35076361 [TBL] [Abstract][Full Text] [Related]
3. Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project. Kotov R; Fochtmann L; Li K; Tanenberg-Karant M; Constantino EA; Rubinstein J; Perlman G; Velthorst E; Fett AJ; Carlson G; Bromet EJ Am J Psychiatry; 2017 Nov; 174(11):1064-1074. PubMed ID: 28774193 [TBL] [Abstract][Full Text] [Related]
4. Genetic contribution to disease-course severity and progression in the SUPER-Finland study, a cohort of 10,403 individuals with psychotic disorders. Kämpe A; Suvisaari J; Lähteenvuo M; Singh T; Ahola-Olli A; Urpa L; Haaki W; Hietala J; Isometsä E; Jukuri T; Kampman O; Kieseppä T; Lahdensuo K; Lönnqvist J; Männynsalo T; Paunio T; Niemi-Pynttäri J; Suokas K; Tuulio-Henriksson A; Veijola J; Wegelius A; ; Daly M; Taylor J; Kendler KS; Palotie A; Pietiläinen O Mol Psychiatry; 2024 Sep; 29(9):2733-2741. PubMed ID: 38556557 [TBL] [Abstract][Full Text] [Related]
5. Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar Disorder. Allardyce J; Leonenko G; Hamshere M; Pardiñas AF; Forty L; Knott S; Gordon-Smith K; Porteous DJ; Haywood C; Di Florio A; Jones L; McIntosh AM; Owen MJ; Holmans P; Walters JTR; Craddock N; Jones I; O'Donovan MC; Escott-Price V JAMA Psychiatry; 2018 Jan; 75(1):28-35. PubMed ID: 29167880 [TBL] [Abstract][Full Text] [Related]
6. Obstetric Complications and Polygenic Risk Score: Which Role in Predicting a Severe Short-Term Outcome in Psychosis? Tosato S; Bonetto C; Vassos E; Lasalvia A; De Santi K; Gelmetti M; Cristofalo D; Richards A; Ruggeri M; On Behalf Of The Picos-Veneto Group Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946845 [TBL] [Abstract][Full Text] [Related]
7. Schizophrenia polygenic risk score in psychosis proneness. Mas-Bermejo P; Papiol S; Via M; Rovira P; Torrecilla P; Kwapil TR; Barrantes-Vidal N; Rosa A Eur Arch Psychiatry Clin Neurosci; 2023 Dec; 273(8):1665-1675. PubMed ID: 37301774 [TBL] [Abstract][Full Text] [Related]
8. Polygenic risk scores across the extended psychosis spectrum. Smigielski L; Papiol S; Theodoridou A; Heekeren K; Gerstenberg M; Wotruba D; Buechler R; Hoffmann P; Herms S; Adorjan K; Anderson-Schmidt H; Budde M; Comes AL; Gade K; Heilbronner M; Heilbronner U; Kalman JL; Klöhn-Saghatolislam F; Reich-Erkelenz D; Schaupp SK; Schulte EC; Senner F; Anghelescu IG; Arolt V; Baune BT; Dannlowski U; Dietrich DE; Fallgatter AJ; Figge C; Jäger M; Juckel G; Konrad C; Nieratschker V; Reimer J; Reininghaus E; Schmauß M; Spitzer C; von Hagen M; Wiltfang J; Zimmermann J; Gryaznova A; Flatau-Nagel L; Reitt M; Meyers M; Emons B; Haußleiter IS; Lang FU; Becker T; Wigand ME; Witt SH; Degenhardt F; Forstner AJ; Rietschel M; Nöthen MM; Andlauer TFM; Rössler W; Walitza S; Falkai P; Schulze TG; Grünblatt E Transl Psychiatry; 2021 Nov; 11(1):600. PubMed ID: 34836939 [TBL] [Abstract][Full Text] [Related]
9. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study. Quattrone D; Reininghaus U; Richards AL; Tripoli G; Ferraro L; Quattrone A; Marino P; Rodriguez V; Spinazzola E; Gayer-Anderson C; Jongsma HE; Jones PB; La Cascia C; La Barbera D; Tarricone I; Bonora E; Tosato S; Lasalvia A; Szöke A; Arango C; Bernardo M; Bobes J; Del Ben CM; Menezes PR; Llorca PM; Santos JL; Sanjuán J; Arrojo M; Tortelli A; Velthorst E; Berendsen S; de Haan L; Rutten BPF; Lynskey MT; Freeman TP; Kirkbride JB; Sham PC; O'Donovan MC; Cardno AG; Vassos E; van Os J; Morgan C; Murray RM; Lewis CM; Di Forti M; Transl Psychiatry; 2021 Aug; 11(1):423. PubMed ID: 34376640 [TBL] [Abstract][Full Text] [Related]
10. Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study. van Os J; Pries LK; Delespaul P; Kenis G; Luykx JJ; Lin BD; Richards AL; Akdede B; Binbay T; Altınyazar V; Yalınçetin B; Gümüş-Akay G; Cihan B; Soygür H; Ulaş H; Cankurtaran EŞ; Kaymak SU; Mihaljevic MM; Petrovic SA; Mirjanic T; Bernardo M; Cabrera B; Bobes J; Saiz PA; García-Portilla MP; Sanjuan J; Aguilar EJ; Santos JL; Jiménez-López E; Arrojo M; Carracedo A; López G; González-Peñas J; Parellada M; Maric NP; Atbaşoğlu C; Ucok A; Alptekin K; Saka MC; ; Arango C; O'Donovan M; Rutten BPF; Guloksuz S Psychol Med; 2020 Aug; 50(11):1884-1897. PubMed ID: 31414981 [TBL] [Abstract][Full Text] [Related]
11. Genetic and psychosocial stressors have independent effects on the level of subclinical psychosis: findings from the multinational EU-GEI study. Pignon B; Peyre H; Ayrolles A; Kirkbride JB; Jamain S; Ferchiou A; Richard JR; Baudin G; Tosato S; Jongsma H; de Haan L; Tarricone I; Bernardo M; Velthorst E; Braca M; Arango C; Arrojo M; Bobes J; Del-Ben CM; Di Forti M; Gayer-Anderson C; Jones PB; La Cascia C; Lasalvia A; Menezes PR; Quattrone D; Sanjuán J; Selten JP; Tortelli A; Llorca PM; van Os J; Rutten BPF; Murray RM; Morgan C; Leboyer M; Szöke A; Schürhoff F Epidemiol Psychiatr Sci; 2022 Sep; 31():e68. PubMed ID: 36165168 [TBL] [Abstract][Full Text] [Related]
12. Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis. Zhang JP; Robinson D; Yu J; Gallego J; Fleischhacker WW; Kahn RS; Crespo-Facorro B; Vazquez-Bourgon J; Kane JM; Malhotra AK; Lencz T Am J Psychiatry; 2019 Jan; 176(1):21-28. PubMed ID: 30392411 [TBL] [Abstract][Full Text] [Related]
13. Psychotic patients who used cannabis frequently before illness onset have higher genetic predisposition to schizophrenia than those who did not. Aas M; Melle I; Bettella F; Djurovic S; Le Hellard S; Bjella T; Ringen PA; Lagerberg TV; Smeland OB; Agartz I; Andreassen OA; Tesli M Psychol Med; 2018 Jan; 48(1):43-49. PubMed ID: 28967348 [TBL] [Abstract][Full Text] [Related]
14. Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum. Pries LK; Dal Ferro GA; van Os J; Delespaul P; Kenis G; Lin BD; Luykx JJ; Richards AL; Akdede B; Binbay T; Altınyazar V; Yalınçetin B; Gümüş-Akay G; Cihan B; Soygür H; Ulaş H; Şahin Cankurtaran E; Ulusoy Kaymak S; Mihaljevic MM; Andric Petrovic S; Mirjanic T; Bernardo M; Mezquida G; Amoretti S; Bobes J; Saiz PA; García-Portilla MP; Sanjuan J; Aguilar EJ; Santos JL; Jiménez-López E; Arrojo M; Carracedo A; López G; González-Peñas J; Parellada M; Maric NP; Atbaşoğlu C; Ucok A; Alptekin K; Can Saka M; ; Arango C; O'Donovan M; Tosato S; Rutten BPF; Guloksuz S Epidemiol Psychiatr Sci; 2020 Nov; 29():e182. PubMed ID: 33200977 [TBL] [Abstract][Full Text] [Related]
15. Polygenic risk scores distinguish patients from non-affected adult relatives and from normal controls in schizophrenia and bipolar disorder multi-affected kindreds. Boies S; Mérette C; Paccalet T; Maziade M; Bureau A Am J Med Genet B Neuropsychiatr Genet; 2018 Apr; 177(3):329-336. PubMed ID: 29193655 [TBL] [Abstract][Full Text] [Related]
16. Long-term Changes in Cognitive Functioning in Individuals With Psychotic Disorders: Findings From the Suffolk County Mental Health Project. Fett AJ; Velthorst E; Reichenberg A; Ruggero CJ; Callahan JL; Fochtmann LJ; Carlson GA; Perlman G; Bromet EJ; Kotov R JAMA Psychiatry; 2020 Apr; 77(4):387-396. PubMed ID: 31825511 [TBL] [Abstract][Full Text] [Related]
17. Polygenic risk score and the psychosis continuum model. Tesli M; Espeseth T; Bettella F; Mattingsdal M; Aas M; Melle I; Djurovic S; Andreassen OA Acta Psychiatr Scand; 2014 Oct; 130(4):311-7. PubMed ID: 24961959 [TBL] [Abstract][Full Text] [Related]
18. Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series? Craig TJ; Bromet EJ; Fennig S; Tanenberg-Karant M; Lavelle J; Galambos N Am J Psychiatry; 2000 Jan; 157(1):60-6. PubMed ID: 10618014 [TBL] [Abstract][Full Text] [Related]
19. Interplay between Schizophrenia Polygenic Risk Score and Childhood Adversity in First-Presentation Psychotic Disorder: A Pilot Study. Trotta A; Iyegbe C; Di Forti M; Sham PC; Campbell DD; Cherny SS; Mondelli V; Aitchison KJ; Murray RM; Vassos E; Fisher HL PLoS One; 2016; 11(9):e0163319. PubMed ID: 27648571 [TBL] [Abstract][Full Text] [Related]
20. Genetic liability in individuals at ultra-high risk of psychosis: A comparison study of 9 psychiatric traits. Lim K; Lam M; Huang H; Liu J; Lee J PLoS One; 2020; 15(12):e0243104. PubMed ID: 33264322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]